X @Bloomberg
Bloomberg·2026-04-17 17:48
Kailera Therapeutics shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized US initial public offering https://t.co/cVgsT45ODa ...
Kailera Therapeutics shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized US initial public offering https://t.co/cVgsT45ODa ...